Article Details

Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b ...

Retrieved on: 2024-01-19 13:32:58

Tags for this article:

Click the tags to see associated articles and topics

Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b .... View article details on hiswai:

Excerpt

10,000-subject Phase 2b study would evaluate Vaxart's next generation oral pill XBB COVID-19 vaccine against an approved mRNA vaccine comparator -.

Article found on: investors.vaxart.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up